Cargando…

Difference in agr Dysfunction and Reduced Vancomycin Susceptibility between MRSA Bacteremia Involving SCCmec Types IV/IVa and I–III

BACKGROUND: Dysfunction of agr, with reduced susceptibility or hetero-resistance to vancomycin, is thought to be associated with a worse outcome of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia (MRSAB). However, the difference in agr dysfunction according to the SCCmec type in MRSA i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Hee-Chang, Kang, Seung-Ji, Choi, Su-Mi, Park, Kyung-Hwa, Shin, Jong-Hee, Choy, Hyon E., Jung, Sook-In, Kim, Hong Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495764/ https://www.ncbi.nlm.nih.gov/pubmed/23152862 http://dx.doi.org/10.1371/journal.pone.0049136

Ejemplares similares

Impact of agr dysfunction on virulence profiles and infections associated with a novel methicillin-resistant Staphylococcus aureus (MRSA) variant of the lineage ST1-SCCmec IV
por: Ferreira, Fabienne Antunes, et al.
Publicado: (2013)

Mobile Genetic Element SCCmec-encoded psm-mec RNA Suppresses Translation of agrA and Attenuates MRSA Virulence
por: Kaito, Chikara, et al.
Publicado: (2013)

Synergistic antimicrobial effect of ascorbic acid and nicotinamide with rifampicin and vancomycin against SCCmec type IV methicillin-resistant Staphylococcus aureus (MRSA)
por: AlSaleh, Abdullah, et al.
Publicado: (2023)

Increased Incidence and Plasma-Biofilm Formation Ability of SCCmec Type IV Methicillin-Resistant Staphylococcus aureus (MRSA) Isolated From Patients With Bacteremia
por: Hamada, Masakaze, et al.
Publicado: (2021)

Complete Genome Sequence of Staphylococcus aureus XN108, an ST239-MRSA-SCCmec III Strain with Intermediate Vancomycin Resistance Isolated in Mainland China
por: Zhang, Xia, et al.
Publicado: (2014)

Genetic diversity of Staphylococcus aureus strains from a teaching hospital in Isfahan, Iran: The emergence of MRSA ST639- SCCmec III and ST343- SCCmec III
por: Sedaghat, Hossein, et al.
Publicado: (2018)

474 Ceftaroline Salvage Therapy for MRSA Bacteremia Following Vancomycin Failure
por: Pettit, Natasha, et al.
Publicado: (2014)

1239. Ceftaroline versus Vancomycin as First-Line Therapy for MRSA Bacteremia
por: Kamath, Meghan, et al.
Publicado: (2021)

Impact of agr Functionality on the Outcome of Patients with Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Lee, Jeong Eun, et al.
Publicado: (2021)

Risk factors of treatment failure and 30-day mortality in patients with bacteremia due to MRSA with reduced vancomycin susceptibility
por: Yang, Chien-Chang, et al.
Publicado: (2018)

Impact of Vancomycin-Associated Acute Kidney Injury on Patient Outcomes in MRSA Bacteremia
por: Luther, Megan, et al.
Publicado: (2017)

Role of SCCmec type in resistance to the synergistic activity of oxacillin and cefoxitin in MRSA
por: Reichmann, Nathalie T., et al.
Publicado: (2017)

Prevalence and clonality of methicillin-resistant Staphylococcus aureus (MRSA) in the Atlantic Azores islands: predominance of SCCmec types IV, V and VI
por: Conceição, T., et al.
Publicado: (2010)

Pacemaker-associated infection caused by ST81/SCCmec IV methicillin-resistant, vancomycin-intermediate Staphylococcus aureus in Japan
por: Sakurada, M., et al.
Publicado: (2020)

The Cefazolin Inoculum Effect and the Presence of type A blaZ Gene according to agr Genotype in Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Lee, Soon Ok, et al.
Publicado: (2019)

Molecular Typing of ST239-MRSA-III From Diverse Geographic Locations and the Evolution of the SCCmec III Element During Its Intercontinental Spread
por: Monecke, Stefan, et al.
Publicado: (2018)

Genotypic characterization of Staphylococcus aureus isolated from a burn centre by using agr, spa and SCCmec typing methods
por: Abbasian, S., et al.
Publicado: (2018)

Intermediate Vancomycin Susceptibility in a Community-associated MRSA Clone
por: Graber, Christopher J., et al.
Publicado: (2007)

Reduced vancomycin susceptibility in porcine ST9 MRSA isolates
por: Kwok, Gabriella M. L., et al.
Publicado: (2013)

Acute MRSA Sinusitis with Intracranial Extension and Marginal Vancomycin Susceptibility
por: Kumar, Parvathi S., et al.
Publicado: (2013)

CC8 MRSA Strains Harboring SCCmec Type IVc are Predominant in Colombian Hospitals
por: Jiménez, J. Natalia, et al.
Publicado: (2012)

Determination of Virulence Factors and Resistance Profile of Methicillin-Resistant Staphylococcus aureus Strains among Different Types of spa, agr, and SCCmec
por: Latifpour, Mohammad, et al.
Publicado: (2022)

Multiresistant ST59-SCCmec IV-t437 clone with strong biofilm-forming capacity was identified predominantly in MRSA isolated from Chinese children
por: Yang, Xin, et al.
Publicado: (2017)

673 Comparative Effectiveness of Vancomycin vs Early Daptomycin for MRSA Bacteremia with Vancomycin MIC >1 mg/L: A Multicenter Evaluation
por: Moise, Pamela, et al.
Publicado: (2014)

Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections
por: Neoh, Hui-min, et al.
Publicado: (2007)

Relationship Status between Vancomycin Loading Dose and Treatment Failure in Patients with MRSA Bacteremia: It’s Complicated
por: Ortwine, Jessica K., et al.
Publicado: (2019)

Dissemination Of t437-SCCmecIV And Coagulase-Negative t037-SCCmecIII Types Among Borderline Oxacillin-Resistant Staphylococcus aureus Isolated From Skin Infections And Diabetic Foot Ulcers
por: Stańkowska, Maria, et al.
Publicado: (2019)

Vancomycin resistance among MRSA
por: Kumar, V. Anil
Publicado: (2012)

Composite SCCmec Element in Single-locus Variant (ST217) of Epidemic MRSA-15 Clone
por: Vignaroli, Carla, et al.
Publicado: (2014)

Assessing Clinical Outcomes of Vancomycin Treatment in Adult Patients with Vancomycin-Susceptible Enterococcus faecium Bacteremia
por: Sasano, Hiroshi, et al.
Publicado: (2023)

Active Surveillance of the Trachea or Throat for MRSA Is More Sensitive than Nasal Surveillance and a Better Predictor of MRSA Infections among Patients in Intensive Care
por: Jang, Hee-Chang, et al.
Publicado: (2014)

High Vancomycin MIC and Complicated Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Aguado, Jose Maria, et al.
Publicado: (2011)

Predominant Dissemination of PVL-Negative CC89 MRSA with SCCmec Type II in Children with Impetigo in Japan
por: Kikuta, H., et al.
Publicado: (2011)

ST9 MRSA strains carrying a variant of type IX SCCmec identified in the Thai community
por: Lulitanond, Aroonlug, et al.
Publicado: (2013)

SCCmec typing of PVL-positive community-acquired Staphylococcus aureus (CA-MRSA) at a Japanese hospital
por: Funaki, Toshitaka, et al.
Publicado: (2019)

High frequency of increased triclosan MIC among CC5 MRSA and risk of misclassification of the SCCmec into types
por: Viana, Alice Slotfeldt, et al.
Publicado: (2022)

The Evolving Reduction of Vancomycin and Daptomycin Susceptibility in MRSA—Salvaging the Gold Standards with Combination Therapy
por: Morrisette, Taylor, et al.
Publicado: (2020)

First report of Staphylococcus pseudintermedius ST71-SCCmec III and ST45-ΨSCCmec(57395) from canine pyoderma in Argentina
por: Srednik, Mariela E., et al.
Publicado: (2023)

Importance of the Global Regulators Agr and SaeRS in the Pathogenesis of CA-MRSA USA300 Infection
por: Montgomery, Christopher P., et al.
Publicado: (2010)

110. MRSA nasal swab as a stewardship tool to guide IV Vancomycin in diabetic foot infections
por: Lazo-Vasquez, Alex, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dm5ikft9j9e98tmpntcesv5cd1